Amicus Briefs

AdvaMed, the medtech association, asked the Supreme Court to affirm the judgments of the court of appeals in the Seventh Circuit in a significant case concerning the False Claims Act (FCA) Scienter Standard.

The Advanced Medical Technology Association (AdvaMed) asked the U.S. Supreme Court to review and reverse a California appeals court’s decision imposing over $300 million in penalties on a medical device manufacturer.

The Advanced Medical Technology Association (AdvaMed) has asked the U.S. Supreme Court to affirm a Third Circuit decision that confirms the government’s right to dismiss qui tam suits under the False Claims Act (FCA).

AdvaMed urged California’s First District Court of Appeal to overturn an erroneous decision by the trial court that has the potential to impose unfair and unwarranted liability upon companies that engage in research to move science forward.

The Advanced Medical Technology Association (AdvaMed) issued the following statement from Pat Fogarty, Senior Vice President, Deputy General Counsel & Director of Litigation regarding this week’s filing of an amicus curiae brief in the case of People v. Johnson & Johnson:

AdvaMed issued a statement regarding the decision from the New Jersey Appellate Division’s decision to remand the McGinnis case for a new trial preceded by Rule 104 hearing on the 510(k) clearance evidence. 

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Pat Fogarty, Vice President, Assistant General Counsel, and Director, Civil Justice Policy regarding yesterday’s oral arguments in front of the New Jersey Superior Court Appellate Division in the case of McGinnis v  C.R. Bard: